We previously reported the antibacterial activity of CD437, a known antitumor compound. It proved to be a potent antimicrobial agent effective against both growing and persister cells of methicillin-resistant Staphylococcus aureus (MRSA). Herein, we report the synthesis of a panel of analogs and their effect on both MRSA and cancer cells. The hydrophobic group of the parent compound was varied in steric bulk, and lipid-mimicking analogs were tested. Biological assessment confirmed that the adamantane moiety is the most effective substitution for antibacterial activity, and some preferential action in cancer over MRSA was achieved.
Bibliographical noteFunding Information:
This work was funded by the National Institute of General Medical Sciences (GM119426) and the Georgia Research Alliance based in Atlanta, Georgia to W.M.W., and by National Institutes of Health grant P01 AI083214 to E.M. The NMR instruments used in this work were supported by the National Science Foundation (CHE1531620).
© 2019 American Chemical Society.
- Methicillin resistant Staphylococcus aureus